Improving Breast Cancer Guideline Adherence in Nigeria
Official title: Improving Adherence to Breast Cancer Treatment Guidelines in Nigeria
Funded at Icahn School of Medicine at Mount Sinai · NIH-11625517 · Data updated 2026-11-12
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 30, 2022 |
| Project end | February 29, 2028 |
| Funding year | 2026 |
| Award (this year) | $16,092 |
| NIH project number | 3K08CA267308-04S1 |
| Project ID | NIH-11625517 on NIH RePORTER |
Who could benefit from this research
✓Could help
Breast cancer patients treated in Nigerian healthcare settings where care is currently inconsistent with guideline-based recommendations.
✕Less likely to help
Patients in settings with already high guideline adherence or where implementation barriers remain insurmountable may see limited or no added benefit.
What this research studies
This project helps Nigerian healthcare teams implement and follow evidence-based breast cancer guidelines in real-world clinics. It will test practical strategies to boost guideline-concordant care in resource-limited settings, with lessons that could also benefit underserved areas in the U.S. The approach includes developing a pilot program and evaluating how well providers adhere to NCCN Harmonized Guidelines for sub-Saharan Africa. Results could guide scalable improvements in breast cancer treatment delivery where access and consistency are challenges.
Why it matters
Potential benefit: If successful, the project could lead to more consistent, guideline-based breast cancer treatment and better survival for women in Nigeria and similar settings.
How similar studies have gone: Previous work suggests guideline-concordant care improves outcomes, and this study builds on that by testing implementation strategies in a new, resource-limited context.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Romanoff, Anya — Icahn School of Medicine at Mount Sinai
- Study coordinator: Romanoff, Anya
Related research
Other NIH-funded projects on the same topics.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
-
Epigenetic clues to how World Trade Center exposures affect breast cancer risk
This project looks at how environmental exposures from the World Trade Center disaster may influence breast cancer risk through changes in DNA methylation.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.